Rainy Season Mosquitoes Prompt Five Florida Counties to Issue Mosquito Borne Illness Health Advisories

~June 18 – 24 is National Mosquito Control Awareness Week; Fight the Bite~ TALLAHASSEE, Fla., June 20, 2023 /PRNewswire/ — Florida’s summer rainy season is falling in full force. More rain leads to more mosquitoes that only require a bottle cap of standing water to breed and spread. National Mosquito Control Awareness Week, June 18-24, … Read more

Athletico Physical Therapy Opens Ravenswood Location in Chicago, Illinois

Athletico is looking forward to continuing its quality of care throughout the state of Illinois CHICAGO, June 20, 2023 /PRNewswire/ — Athletico Physical Therapy has opened a new location in Chicago, Illinois, located in the Ravenswood Plaza, between Giordano’s and Plenty Chinese Restaurant. This location offers convenient hours, including early morning and late evening appointments, … Read more

Veravas Launches Groundbreaking VeraBIND Technology for Ultra-Sensitive Assays and Matrix Free Sample Analysis

Revolutionary bead-based technology enables reliable biomarker detection in challenging samples, transforming clinical diagnostic performance and research workflows AUSTIN, Texas, June 20, 2023 /PRNewswire/ — Today, Veravas, a leading innovator in clinical diagnostics, announced the launch of its groundbreaking VeraBIND™ (Biomarker Isolation and N-richment for Detection) technology. With millions of assays conducted daily in clinical laboratories … Read more

Delcath Systems Appoints Vojislav Vukovic as Chief Medical Officer

NEW YORK, June 20, 2023 /PRNewswire/ — Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr.  Vojislav “Vojo” Vukovic as its new Chief Medical Officer (CMO). Dr. Vukovic is an experienced … Read more

SuperMouth®, the First Dentist-Invented MouthCare Systems for Kids, Launches Nationwide, Celebrates the Summer of Smiles

SAN DIEGO, June 20, 2023 /PRNewswire/ — SuperMouth®, the first dentist-invented mouthcare system for kids, launches nationwide today at SuperMouth.com, kicking-off their Summer of Smiles program. Designed to focus on whole mouth health, SuperMouth is a revolutionary approach to oral care that includes the safest and most effective ingredients, parent-targeted educational resources, and branded entertainment content … Read more

DiamiR Biosciences Announces Two Poster Presentations at 2023 Alzheimer’s Association International Conference

NEW HAVEN, Conn.and MONMOUTH JUNCTION, N.J., June 20, 2023 /PRNewswire/ — DiamiR Biosciences, a developer of innovative non-invasive blood-based diagnostic tests for brain health and other diseases, today announced that it will present two posters at the Alzheimer’s Association International Conference (AAIC), taking place July 16 – 20, 2023, in Amsterdam, Netherlands, and online. Title:  … Read more

Trulieve Opening Relocated Medical Marijuana Dispensary in Fort Myers, FL

New dispensary hosts grand opening event and expands patient access to medical cannabis TALLAHASSEE, Fla., June 20, 2023 /PRNewswire/ — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, announced the relocation of a medical dispensary in Fort Myers, Florida. Located at 5660 Bayshore … Read more

GoodRx Executive Andrew Slutsky Joins SteadyMD Board

LOS ANGELES and ST. LOUIS, June 20, 2023 /PRNewswire/ — SteadyMD, a B2B telehealth infrastructure provider that powers high-quality telehealth patient experiences for leaders and innovators in healthcare, is pleased to announce that Andrew Slutsky, senior vice president of strategic marketing innovation at GoodRx, has joined its board of directors. “We’re thrilled to have Andrew Slutsky … Read more

Precigen Receives Breakthrough Therapy Designation for PRGN-2012 AdenoVerse™ Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis

–  First FDA Breakthrough Therapy Designation granted for AdenoVerse immunotherapy platform; designation prioritizes PRGN-2012 as a potential treatment for RRP ––  Designation based on positive Phase 1 clinical data that showed 50% of patients were “surgery-free” (Complete Response) after PRGN-2012 treatment with a minimum follow up of 12 months post-treatment – GERMANTOWN, Md. , June 20, … Read more